$AIMD
Ainos, Inc.

2019 Q1 Form 10-Q Financial Statement

#000101476319000007 Filed on May 17, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1
Revenue $4.076K $56.59K
YoY Change -92.8%
Cost Of Revenue $2.718K $43.34K
YoY Change -93.73%
Gross Profit $1.358K $13.25K
YoY Change -89.75%
Gross Profit Margin 33.32% 23.42%
Selling, General & Admin $389.5K $199.3K
YoY Change 95.41% 7.73%
% of Gross Profit 28680.12% 1504.11%
Research & Development $2.386K
YoY Change
% of Gross Profit 175.7%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $391.9K $199.3K
YoY Change 96.61% 7.73%
Operating Profit -$390.5K -$186.1K
YoY Change 109.88% 0.56%
Interest Expense $885.00 $1.380K
YoY Change -35.87% -65.14%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$390.0K -$190.0K
YoY Change 105.26% 0.0%
Income Tax
% Of Pretax Income
Net Earnings -$391.4K -$187.4K
YoY Change 108.81% -0.81%
Net Earnings / Revenue -9602.28% -331.22%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.15 -$0.08
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.050M $1.710M
YoY Change -38.6% 3320.0%
Cash & Equivalents $1.046M $1.707M
Short-Term Investments
Other Short-Term Assets $20.00K $10.00K
YoY Change 100.0% -90.0%
Inventory $8.962K
Prepaid Expenses
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $1.071M $1.719M
YoY Change -37.69% 1029.17%
LONG-TERM ASSETS
Property, Plant & Equipment $11.02K $22.69K
YoY Change -51.46% -43.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $154.6K $201.0K
YoY Change -23.08% 2.59%
TOTAL ASSETS
Total Short-Term Assets $1.071M $1.719M
Total Long-Term Assets $154.6K $201.0K
Total Assets $1.226M $1.920M
YoY Change -36.17% 451.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $140.0K $140.0K
YoY Change 0.0% 0.0%
Accrued Expenses
YoY Change
Deferred Revenue $7.491K
YoY Change
Short-Term Debt $480.0K $690.0K
YoY Change -30.43% -12.66%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $673.8K $1.140M
YoY Change -40.91% -9.06%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $673.8K $1.140M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $673.8K $1.140M
YoY Change -40.91% -9.06%
SHAREHOLDERS EQUITY
Retained Earnings -$3.580M -$2.153M
YoY Change 66.3% 47.89%
Common Stock $395.7K $337.2K
YoY Change 17.33% 50.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $552.1K $698.9K
YoY Change
Total Liabilities & Shareholders Equity $1.226M $1.920M
YoY Change -36.17% 451.6%

Cashflow Statement

Concept 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income -$391.4K -$187.4K
YoY Change 108.81% -0.81%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$216.2K -$76.52K
YoY Change 182.53% -39.51%
INVESTING ACTIVITIES
Capital Expenditures $1.638K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.638K -$1.687K
YoY Change -2.9% -67.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -12.50K -195.0K
YoY Change -93.59% -485.19%
NET CHANGE
Cash From Operating Activities -216.2K -76.52K
Cash From Investing Activities -1.638K -1.687K
Cash From Financing Activities -12.50K -195.0K
Net Change In Cash -230.3K -273.2K
YoY Change -15.69% 236.66%
FREE CASH FLOW
Cash From Operating Activities -$216.2K -$76.52K
Capital Expenditures $1.638K
Free Cash Flow -$217.8K -$76.52K
YoY Change 184.67% -43.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 amar Common Stock Shares Outstanding And Reserved
CommonStockSharesOutstandingAndReserved
47989122
CY2019Q1 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
475856
CY2018Q4 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
513356
CY2019Q1 amar Repayments Of Convertible Notes Payable Related Party Debt
RepaymentsOfConvertibleNotesPayableRelatedPartyDebt
37500
CY2018Q1 amar Repayments Of Convertible Notes Payable Related Party Debt
RepaymentsOfConvertibleNotesPayableRelatedPartyDebt
195000
CY2019Q1 amar Stock Issued For Accrued Liabilities
StockIssuedForAccruedLiabilities
82750
CY2018Q1 amar Stock Issued For Accrued Liabilities
StockIssuedForAccruedLiabilities
496736
CY2019Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
141674
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
115313
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3736123
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3527238
CY2019Q1 us-gaap Assets
Assets
1225840
CY2018Q4 us-gaap Assets
Assets
1463700
CY2019Q1 us-gaap Assets Current
AssetsCurrent
1071278
CY2018Q4 us-gaap Assets Current
AssetsCurrent
1303234
CY2019Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: &quot;Times New Roman&quot;; font-size: 10pt; min-width: 700px;"> <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="width: 27pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Basis of presentation.</div> The accompanying consolidated financial statements, which should be read in conjunction with the audited financial statements and footnotes included in the Company's Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>as filed with the Securities and Exchange Commission on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 16, 2019, </div>have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2019 </div>are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of the results that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be expected for the full year ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019.</div></div> </td> </tr> </table></div>
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1046314
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1276654
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1980015
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1706804
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-230340
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-273211
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39568524
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39117524
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39568524
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39117524
CY2019Q1 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
2627305
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
395685
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
391175
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
2718
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
43339
CY2019Q1 us-gaap Dividends
Dividends
0
CY2019Q1 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
56225
CY2018Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
104952
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2019Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
143546
CY2018Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
146456
CY2019Q1 us-gaap Gross Profit
GrossProfit
1358
CY2018Q1 us-gaap Gross Profit
GrossProfit
13251
CY2019Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2018Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2019Q1 us-gaap Interest Expense
InterestExpense
885
CY2018Q1 us-gaap Interest Expense
InterestExpense
1380
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
69
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
3819
CY2019Q1 us-gaap Inventory Net
InventoryNet
8962
CY2018Q4 us-gaap Inventory Net
InventoryNet
CY2019Q1 us-gaap Liabilities
Liabilities
673755
CY2018Q4 us-gaap Liabilities
Liabilities
733621
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1225840
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1463700
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
673755
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
733621
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12500
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-195000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1638
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1687
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-216202
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-76524
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-391389
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-187438
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
CY2018Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4992
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-391389
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-192430
CY2019Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
391862
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
199309
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-390504
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-186058
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2386
CY2019Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
CY2018Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1687
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1638
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16002
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26580
CY2019Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
25000
CY2018Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11016
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14010
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3579723
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3188334
CY2019Q1 us-gaap Revenues
Revenues
4076
CY2018Q1 us-gaap Revenues
Revenues
56590
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
389476
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
199309
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
552085
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
730079
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39262668
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33243580

Files In Submission

Name View Source Status
0001014763-19-000007-index-headers.html Edgar Link pending
0001014763-19-000007-index.html Edgar Link pending
0001014763-19-000007.txt Edgar Link pending
0001014763-19-000007-xbrl.zip Edgar Link pending
amar-20190331.xml Edgar Link completed
amar-20190331.xsd Edgar Link pending
amar-20190331_cal.xml Edgar Link unprocessable
amar-20190331_def.xml Edgar Link unprocessable
amar-20190331_lab.xml Edgar Link unprocessable
amar-20190331_pre.xml Edgar Link unprocessable
exhibit31-1a_03312019.htm Edgar Link pending
exhibit31-1b_03312019.htm Edgar Link pending
exhibit32-1_03312019.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q_03312019.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending